chronic obstructive pulmonary disease
Conditions
Interventions
Group 1 :acupuncture once a week plus Conventional medication
Group 2:acupuncture twice a week plus Conventional medication
Group 3:acupuncture three times a week plus Conventional medication
Group 4:sham-acupuncture plus Conventional medication
Group 5:Conventional medication
Sponsors
Chengdu University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
40 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Patients diagnosed with COPD, and without acute exacerbation in the last 4 weeks; 2. Aged between 40 and 80 years old, both sexes; 3. Patients with FEV1 between 25% and 80% after inhaled bronchodilators; 4. Patients with at least one moderate or severe acute exacerbation within the past year; 5. Patients on stable western medical therapy within 3 months prior to treatment according to the GOLD recommended dosing regimen; 6. Patients are willing to cooperate with the study and sign an informed consent form.
Exclusion criteria
Exclusion criteria: 1. Subjects with severe cardiovascular (severe arrhythmia, heart attack, heart failure, severe hypertension, cerebral hemorrhage, and cerebral infarction), neurological (tremor, peripheral neuropathy), hematological (severe anemia, etc.), immune system (immune disease combined with lung damage), malignant tumors, etc.; 2. Subjects with active tuberculosis, bronchial asthma, severe bronchiectasis, primary pulmonary hypertension, interstitial lung disease, or other active lung diseases; 3. Subjects with post-pulmonary segmental resection, post-wedge resection or post lobectomy, post-total pneumonectomy, or who have undergone lung volume reduction (including bronchoscopic lung volume reduction) because of COPD; 4. Subjects with continuous oxygen therapy according to LTOT criteria (duration of oxygen therapy > 15 h/d); 5. Subjects cannot cooperate in completing pulmonary function tests, cannot walk independently, or cannot cooperate in completing questionnaires; 6. Patients with persistent skin tissue breakdown, infection and coagulation dysfunction at the acupuncture site, and skin allergy; 7. Patients participated in other clinical trials or underwent acupuncture for respiratory diseases within the last 3 months; 8. Pregnant and lactating women.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| St George's respiratory questionnaire; | — |
Secondary
| Measure | Time frame |
|---|---|
| Modified Medical Research Council; The COPD Assessment Test (CAT);6 minutes walking distance;SF-36 quality of life score;Number of moderate and severe acute exacerbations in COPD patients during the follow-up period; | — |
Countries
China
Contacts
Public ContactFanrong Liang
Chengdu University of Traditional Chinese Medicine
Outcome results
None listed